These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4677715)

  • 1. Clofibrate and fat embolism.
    McPherson JC; Harms WS; Ellison LT; Ellison RG
    Br Med J; 1972 Aug; 3(5824):473. PubMed ID: 4677715
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethyl-2-(p-chlorophenoxy)-2-methylpropionate (clofibrate) in experimental fat embolism in rats.
    Baker PL; Kantor JH; Kuenzig M; Peltier LF
    Proc Soc Exp Biol Med; 1971 Jan; 136(1):64-5. PubMed ID: 5540640
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of corticosteroids on lung surfactant activity in experimentally produced fat embolism in rats.
    Stitt RW; Adler F
    Surg Forum; 1977; 28():491-2. PubMed ID: 581528
    [No Abstract]   [Full Text] [Related]  

  • 4. The consequences of intravenous clofibrate and its implications in the treatment of fat embolism.
    McPherson JC; Dirksen TR; Howard JC
    J Trauma; 1981 Feb; 21(2):157-9. PubMed ID: 7206007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fat embolism.
    Riseborough EJ
    Am Fam Physician; 1974 Oct; 10(4):80-7. PubMed ID: 4479127
    [No Abstract]   [Full Text] [Related]  

  • 6. Clofibrate and fat embolism: a double-blind trial of the effects of clofibrate on sequelae to injury.
    Cole WG
    Br Med J; 1971 Oct; 4(5780):148-9. PubMed ID: 4939602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fat embolism and proteinase inhibitors].
    Mörl FK; Heller W
    Langenbecks Arch Chir; 1969; 325():369-72. PubMed ID: 5309043
    [No Abstract]   [Full Text] [Related]  

  • 8. [Behaviour of serum lipids in the pathogenesis of posttraumatic fat embolism].
    Mörl FK; Heller W
    Bruns Beitr Klin Chir (1971); 1969 Mar; 217(2):132-40. PubMed ID: 5373695
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of clofibrate on the levels of total lipids, cholesterol and beta-lipoproteins in diabetic children].
    Sońta-Jakimczyk D; Otto-Buczkowska E
    Pol Tyg Lek; 1974 Aug; 29(31):1333-4. PubMed ID: 4848574
    [No Abstract]   [Full Text] [Related]  

  • 10. Fat embolism--some clinical observations and a review of controversial aspects.
    Benatar SR; Ferguson AD; Goldschmidt RB
    Q J Med; 1972 Jan; 41(161):85-98. PubMed ID: 4403633
    [No Abstract]   [Full Text] [Related]  

  • 11. Clofibrate and nicotinic acid.
    Hoffer A
    Can Med Assoc J; 1972 Sep; 107(6):488 passim. PubMed ID: 5057001
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of clofibrate on cholesterol induced aortic lesions.
    Fehér J; Bihari-Varga M; Varsáńyi M; Gerö S
    Br J Exp Pathol; 1972 Oct; 53(5):509-17. PubMed ID: 4263718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term administration of clofibrate on the composition of blood lipids in patients with atherosclerosis.
    Poleszak J; Korolko A
    Pol Med J; 1972; 11(2):250-6. PubMed ID: 5071512
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic clofibrate therapy in maintenance hemodialysis patients.
    Sherrard DJ; Goldberg AB; Haas LB; Brunzell JD
    Nephron; 1980; 25(5):219-21. PubMed ID: 7383233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the antilipaemic potential of etofylline clofibrate, its metabolites and clofibrate in dietary-induced hyperlipidaemia in the rat (author's transl)].
    Sterner W; Chibanguza G; Metz G
    Arzneimittelforschung; 1980; 30(11b):2038-41. PubMed ID: 7194056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and therapeutic evaluation of a new antilipemic substance].
    de Aguiar Magano L
    Arch Sci Med (Torino); 1980; 137(1):131-9. PubMed ID: 7458646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fat embolism: evolution of blood lipids].
    Maruenda Paulino A; Belda Nacher FJ; Gallego Rodríguez MV; Badenes Catala R; Barbera Alacreu M; Frasquet Rosich FJ; Company Teuler R; Chulia Campos V
    Rev Esp Anestesiol Reanim; 1980 Mar; 27(2):120-34. PubMed ID: 7422980
    [No Abstract]   [Full Text] [Related]  

  • 18. Injury, serum lipids, fat embolism, and clofibrate.
    O'Driscoll M; Powell FJ
    Br Med J; 1967 Oct; 4(5572):149-51. PubMed ID: 6053980
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influence of the change in the dose of Clofibrate Spofa and interruption of treatment on the lipid level of blood serum in persons with hyperlipemia].
    Cagánová A; Cagán S
    Bratisl Lek Listy; 1972 Jul; 58(1):66-78. PubMed ID: 5077942
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of polyunsaturated phospholipids in the treatment of fat embolism].
    Wattel F; Scherpereel P; Sezille G; Fruchart JC
    Lille Med; 1974 Oct; 19(8 Suppl 3):870-4. PubMed ID: 4463283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.